Immunomodulators in the treatment of cutaneous lymphomas.
about
Lesional skin chemokine CTACK/CCL27 expression in mycosis fungoides and disease control by IFN-alpha and PUVA therapy.Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy.
P2860
Immunomodulators in the treatment of cutaneous lymphomas.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunomodulators in the treatment of cutaneous lymphomas.
@ast
Immunomodulators in the treatment of cutaneous lymphomas.
@en
Immunomodulators in the treatment of cutaneous lymphomas.
@nl
type
label
Immunomodulators in the treatment of cutaneous lymphomas.
@ast
Immunomodulators in the treatment of cutaneous lymphomas.
@en
Immunomodulators in the treatment of cutaneous lymphomas.
@nl
prefLabel
Immunomodulators in the treatment of cutaneous lymphomas.
@ast
Immunomodulators in the treatment of cutaneous lymphomas.
@en
Immunomodulators in the treatment of cutaneous lymphomas.
@nl
P2860
P356
P1476
Immunomodulators in the treatment of cutaneous lymphomas.
@en
P2093
Reinhard Dummer
P2860
P304
P356
10.1517/14712598.2.3.279
P407
P577
2002-03-01T00:00:00Z